SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-034655
Filing Date
2013-04-30
Accepted
2013-04-30 06:05:16
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8536_110q.htm 10-Q 681579
2 EX-10.2 a13-8536_1ex10d2.htm EX-10.2 88732
3 EX-10.3 a13-8536_1ex10d3.htm EX-10.3 69134
4 EX-31.1 a13-8536_1ex31d1.htm EX-31.1 11609
5 EX-31.2 a13-8536_1ex31d2.htm EX-31.2 12076
6 EX-32.1 a13-8536_1ex32d1.htm EX-32.1 8032
  Complete submission text file 0001104659-13-034655.txt   5458589

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snta-20130331.xml EX-101.INS 562702
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20130331.xsd EX-101.SCH 63915
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20130331_cal.xml EX-101.CAL 42208
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20130331_lab.xml EX-101.LAB 1014304
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20130331_pre.xml EX-101.PRE 458079
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20130331_def.xml EX-101.DEF 249178
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 13794193
SIC: 2834 Pharmaceutical Preparations